CVA Family Office’s Neogen NEOG Stock Holding History

CVA Family Office’s Portfolio NEOG Stock Details NEOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-38	Closed	-$2K	–	695
2021 Q2	$2K	Buy	+38	New	+$1.76K	﹤0.01%	890

Other funds holding NEOG

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CVA Family Office's NEOG Position: Q3 2021 in Review

CVA Family Office sold out of Neogen (NEOG) in Q3 2021, closing a stake of 38 shares — an estimated $2K sold.

CVA Family Office first reported a position in NEOG in Q2 2021 and held it in 1 quarter. The position peaked at $2K in Q2 2021. 303 funds tracked by Wall St. Rank hold NEOG as of Q3 2021.

CVA Family Office reported no remaining Neogen position as of Q3 2021 after selling out during the quarter.
CVA Family Office sold 38 Neogen shares in Q3 2021, an estimated $2K.
CVA Family Office first reported a position in Neogen in Q2 2021 and held it in 1 quarter.
CVA Family Office's Neogen position peaked at $2K in Q2 2021.
303 funds tracked by Wall St. Rank held Neogen as of Q3 2021.

Based on CVA Family Office's 13F filing for Q3 2021, filed 12 Oct 2021.